Abstract
To document the existence and clinical characteristics of probands from families with multigenerational inheritance of early onset type 2 diabetes mellitus in Jamaica. Three probands from large families with multigenerational inheritance of early onset type 2 diabetes mellitus in at least three generations were detected at the University Hospital of the West Indies, Jamaica during a screening process for patients with MODY. Clinical, metabolic and genetic assessments were undertaken to ascertain the profile of the diabetes present in the three families. The three probands: patients 1, 2 and 3 were from families with history of ≥ 3 generations of early onset type 2 diabetes mellitus. All were diagnosed before age 25 years. The probands had varying metabolic profiles at the onset of diabetes ranging from decreased insulinaemia to hyperinsulinaemia (4.7 mU/L, 15.6 mU/L, 38.6 mU/L). The HbA1c ranged from 12.1 to 18.4%. Two of the probands were of normal weight, the other obese (30.7 kg/m2). All probands had insulin resistance. Sequence variants in MODY 1–6 genes were absent in the probands and family members. Islet cell antibodies (ICA) were absent in two patients and the families of all three patients. However the third patient had a positive titre for the ICA antibodies. The clinical patterns of the diabetes seen in the three Jamaican families are difficult to include in a single type of diabetes mellitus. It is proposed to name this diabetes process Mosaic Pancreas or type 3 diabetes.
Similar content being viewed by others
References
King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025. Diabetes Care. 1998;21:1414–31.
Ragoobirsingh D, Lewis-Fuller E, Morrison EY. The Jamaican Diabetes Survey. Diabetes Care. 1995;18:1277–9.
Cooper RS, Rotimi CN, Kaufman JS, Owoaje EE, Fraser H, Forrester T, et al. Prevalence of NIDDM among populations of the African diaspora. Diabetes Care. 1997;20:343–8.
Wilks R, Rotimi C, Bennett F, McFarlane-Anderson N, Kaufman JS, Anderson SG, et al. Diabetes in the Caribbean: results of a population survey from Spanish Town, Jamaica. Diabet Med. 1999;16:875–83.
American Diabetes Association. Type 2 diabetes in children and adolescents. Pediatrics. 2000;105:671–80.
Sahay BK, Sahay RK. Type 2 diabetes in the young. Int J Diab Dev Ctries. 2003;23:51–4.
Morrison EY. Diabetes mellitus—a third syndrome (phasic insulin dependence). Int Diab Fed Bull. 1981;26:6.
Banerji MA, Lebovitz HE. Remission in non-insulin-dependent diabetes mellitus. Clinical characteristics of remission and relapse in black patients. Medicine. 1990;69:175–85.
Tan K, MacKay I, Zimmet P, Hawkins B, Lam K. Metabolic and immunologic features of Chinese patients with atypical diabetes mellitus. Diabetes Care. 2000;23:335–8.
Rosenbloom AL, Young RS, Joe JR, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care. 1999;22:345–54.
World Health Organization. Diabetes Mellitus: Report of a WHO Study Group. Geneva: WHO. Technical Report Series 727;1985.
Zuidema PJ. Cirrhosis and disseminated calcification of the pancreas in patients with malnutrition. Trop Geogr Med. 1959;11:70–4.
Ahren B, Corrigan CB. Intermittent need for insulin in a subgroup of diabetic patients in Tanzania. Diabet Med. 1985;2:262–4.
Mohan V, Rema Mohan, Susheela L, Snehalatha C, Bharani G, Mahajan VK, et al. Tropical pancreatic diabetes in south India: heterogeneity in clinical and biochemial profile. Diabetologia. 1985;28:229–32.
Hugh-Jones P. Diabetes in Jamaica. Lancet. 1955;2:891–97.
Tulloch-Reid M. Type 2 diabetes present in youth. American Association of Clinical Endocrinology 16th Annual Meeting and Clinical Congress. Sheraton Seattle Hotel and Towers and the Washington State Convention & Trade Center. April 11–15, 2007.
Irving RR, Mills JL, Choo-Kang EG, Morrison EY, Kulkarni S, Wright-Pascoe R, et al. The burden of gestational diabetes mellitus in Jamaican women with a family history of autosomal dominant type 2 diabetes. Pan Am Health Org. 2008;23:85–91.
WHO Consultation. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, WHO/NCD/NCS/99.2, 1999 World Health Org; 1999.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.
Fulteron RE, Salasek ML, DuTeau NM, Black WC. SSCP analysis of cDNC markers provides a dense linkage map of the Aedes Aegypti genome. Genetics. 2001;158:715–26.
Aguilar-Salinas CA, Reyes-Rodriquez E, Ordonez-Sanchez MA, Torres MA, Ramirez-Jimenez S, Dominquez-Lopez A, et al. Early onset type 2 diabetes: metabolic and genetic characterization in the Mexican population. J Clin Endocrinol Metab. 2001;86:220–26.
Winter W, MacLaren NK, Riley WJ, Clarke DW, Kappy MS, Spillar RP. Maturity onset diabetes of the youth in back Americans. N Engl J Med. 1985;316:285–91.
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183–97.
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–53.
Banerji MA, Lebovitz HE. Insulin sensitive and insulin resistant variants in NIDDM. Diabetes. 1989;38:784–92.
Eisenbarth GS. Type I. diabetes mellitus: a chronic autoimmune disease. N Engl J Med. 1986;314:1360–8.
Bach JF. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev. 1994;15:516–42.
Juneja R, Palmer JP. Type 1 1/2 diabetes: myth or reality. Autoimmunity. 1999;29:65–83.
Irvine WJ, Gray RS, McCallum CJ, Duncan LJP. Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetics treated with oral hypoglycemic agents. Lancet. 1977;1:1025–7.
Gottsater A, Landin-Olsson M, Fernlund P, Lernmark A, Sundkvist G. Beta- cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients. Diabetes Care. 1993;16:902–10.
Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction [Published correction appears in Endocr Rev 2002;23:579]. Endocr Rev. 2002;23:327–64.
Zimmet PZ. The pathogenesis and prevention of diabetes in adults: genes, autoimmunity, and demography. Diabetes Care. 1994;18:1050–64.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Irving, R.R., Wright-Pascoe, R., Mills, J.L. et al. Mosaic pancreas or type 3 diabetes: how do we define it?. Int J Diabetes Dev Ctries 31, 133–137 (2011). https://doi.org/10.1007/s13410-011-0028-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13410-011-0028-0